Ethical Compliance
PFIZER
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Market Cap Class:
large
Revenue
7.6%
Debt
0.1%
Liquidity
51.1%
Revenue
Debt
Liquidity
7.6%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharma products | ₹2,081.04 |
| Sale of Services | ₹111.65 |
| Scrap sales | ₹0.48 |
Questionable
INR Crores
Non Compliant
INR Crores
| interest & other | ₹171.59 |
| other income | ₹8.92 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹180.51 |
| Total: | ₹180.51 |
| Total Revenue: | ₹2,373.68 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹180.51
₹2,373.68
= 7.6%
non-compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.